Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons by 源��룞�슧
Genetic engineering of mouse embryonic stem cells by
Nurr1 enhances differentiation and maturation into
dopaminergic neurons
Sangmi Chung,1,2,3 Kai-C. Sonntag,1,2,3 Therese Andersson,1,2,3 Lars M. Bjorklund,1,2 Jae-Joon Park,1,3
Dong-Wook Kim,1,3 Un Jung Kang,4 Ole Isacson,1,2 Kwang-Soo Kim,1,3
1Udall Parkinson's Disease Research Center of Excellence,
2Neuroregeneration Laboratories and
3Molecular Neurobiology Laboratories; McLean Hospital/Harvard Medical School, Belmont, MA, 02478, USA
4Department of Neurology, The University of Chicago, Chicago, IL
Keywords: differentiation, dopaminergic neuron, ES cell, Nurr1, Parkinson's disease, transcription factor
Abstract
Nurr1 is a transcription factor critical for the development of midbrain dopaminergic (DA) neurons. This study modi®ed mouse
embryonic stem (ES) cells to constitutively express Nurr1 under the elongation factor-1a promoter. The Nurr1-expression in
ES cells lead to up-regulation of all DA neuronal markers tested, resulting in about a 4- to 5-fold increase in the proportion of
DA neurons. In contrast, other neuronal and glial markers were not signi®cantly changed by Nurr1 expression. It was also
observed that there was an additional 4-fold increase in the number of DA neurons in Nurr1-expressing clones following
treatment with Shh, FGF8 and ascorbic acid. Several lines of evidence suggest that these neurons may represent midbrain
DA neuronal phenotypes; ®rstly, they coexpress midbrain DA markers such as aromatic L-amino acid decarboxylase, calretinin,
and dopamine transporter, in addition to tyrosine hydroxylase and secondly, they do not coexpress other neurotransmitters such
as GABA or serotonin. Finally, consistent with an increased number of DA neurons, the Nurr1 transduction enhanced the ability
of these neurons to produce and release DA in response to membrane depolarization. This study demonstrates an ef®cient
genetic manipulation of ES cells that facilitates differentiation to midbrain DA neurons, and it will serve as a framework of genetic
engineering of ES cells by key transcription factor to regulate their cell fate.
Introduction
This study examines the hypothesis that exogenous expression of a
critical transcription factor may facilitate the differentiation of
embryonic stem (ES) cells toward certain cell lineages. ES cells are
derived from the inner cell mass of preimplantation mouse embryos
(Evans & Kaufman, 1981; Martin, 1981) and represent pluripotent
cells that can give rise to most cell types in the embryo (Nagy et al.,
1990; Nagy et al., 1993). ES cells can be maintained in vitro as
pluripotent cells, or differentiated into different cell lineages (Smith,
1991; Desbaillets et al., 2000). These unique properties make ES cells
a useful tool to analyse critical steps of cell development, using both
animal models as well as in vitro differentiation culture systems
(Hooper et al., 1987; Thomas & Capecchi, 1987; Nagy et al., 1990;
Nagy et al., 1993; Dinsmore et al., 1996; Wutz & Jaenisch, 2000). In
addition, the capacity of ES cells to generate terminally differentiated
cell types provides a potentially unlimited resource for cell replace-
ment therapy (Dinsmore et al., 1996; Brustle et al., 1999; Lumelsky
et al., 2001; BjoÈrklund et al., 2002).
Parkinson's disease (PD) primarily involves degenerative loss of
midbrain dopaminergic (DA) neurons. For therapeutic application of
stem cells in PD, it is therefore critical to identify the signalling
molecules that specify the cell fate of midbrain DA neurons. In
addition, dysregulation of DA neurotransmission has been implicated
in other brain disorders such as drug addiction and schizophrenia.
During the last several years, signalling molecules, e.g. sonic
hedgehog (Shh), ®broblast growth factors (FGF) 4 and 8, that
in¯uence the cell fate determination of DA neurons have been
identi®ed (Hynes & Rosenthal, 1999). It is thought that such signals
lead to induction of speci®c transcription factors which in turn
regulate expression of target molecules necessary for speci®cation of
these particular cell types (Goridis & Brunet, 1999). Therefore, one
strategy for directing stem cells to a desired neuronal phenotype is to
exogenously express key transcription factors.
Nurr1 belongs to the orphan nuclear receptor family (Law et al.,
1992), and this transcription factor is relatively enriched in the
developing and adult substantia nigra (Zetterstrom et al., 1996;
Backman et al., 1999). As Nurr1 has been implicated in the
phenotypic speci®cation of midbrain DA neurons in vivo (Zetterstrom
et al., 1997; Castillo et al., 1998; Saucedo-Cardenas et al., 1998), it is
reasonable to speculate that exogenous expression of this transcrip-
tion factor would facilitate DA differentiation. Recently the function
of Nurr1 has been studied in recombinant neural precursor cells such
as adult hippocampus precursors (Sakurada et al., 1999) and the
cerebellum-derived immortalized cell line C17.2 (Wagner et al.,
1999). Both studies showed that exogenous expression of Nurr1 leads
to induction of tyrosine hydroxylase (TH), although by seemingly
Correspondence: Dr Kwang-Soo Kim or Dr Ole Isacson, as above.
E-mail: kskim@mclean.harvard.edu or isacson@hms.harvard.edu
Received 13 June 2002, revised 8 August 2002, accepted 30 August 2002
doi:10.1046/j.1460-9568.2002.02255.x
European Journal of Neuroscience, Vol. 16, pp. 1829±1838, 2002 ã Federation of European Neuroscience Societies
different mechanisms. Sakurada et al., (1999) demonstrated that
Nurr1 binds directly to the TH gene promoter, resulting in induction
of TH, in the absence of neuronal differentiation and without the
expression of other DA markers. In contrast, Wagner et al., (1999)
showed that Nurr1 can induce TH expression in C17.2 cells only
when cocultured with ventral mesencephalic type 1 astrocytes. As in
both studies partially committed precursors had been used, the
observed difference may be due to the speci®c characteristics of those
cells. Therefore, it is of great interest to explore how exogenous
Nurr1 expression may affect the differentiation potential of uncom-
mitted pluripotent ES cells. Here, we generated ES cell lines that
express Nurr1 and demonstrate that the Nurr1-transduction remark-
ably facilitates ES cells to differentiate into the midbrain DA
neuronal lineage in vitro.
Materials and methods
ES cell culture and in vitro differentiation
The mouse blastocyst-derived ES cell line D3 was obtained from
A.T.C.C. (Rockland, MD), propagated and maintained as described
previously (Deacon et al., 1998). In brief, undifferentiated ES cells
were cultured on gelatin-coated dishes in Dulbecco's modi®ed
minimal essential medium (DMEM, Life Technologies, Rockville,
MD) supplemented with 2 mM glutamine (Life Technologies),
0.001% b-mercaptoethanol (Life Technologies), 1 3 nonessential
amino acids (Life Technologies), 10% donor horse serum (Sigma, St.
Louis, MO), and 2000 U/mL human recombinant leukaemia
inhibitory factor (LIF; R & D Systems, Minneapolis, MN).
ES cells were differentiated into embryoid bodies (EBs) on
nonadherent bacterial dishes (Fisher Scienti®c, Pittsburgh, PA) for
four days in EB medium, as described above except for removing LIF
and exchanging horse serum with 10% fetal bovine serum (Hyclone,
Logan, Utah). The EBs were then plated onto adhesive tissue culture
surface (Fisher Scienti®c). After 24 h in culture, selection of neuronal
precursor cells was initiated in serum-free ITSFn medium (Okabe
et al., 1996). After 6±10 days of selection, cells were trypsinized and
nestin+ neuronal precursors were plated on polyornithine (15 mg/mL;
Sigma) and ®bronectin (1 mg/mL; Sigma) coated coverslips in N2
medium (Johe et al., 1996) supplemented with 1 mg/mL laminin
(Sigma) and 10 ng/mL bFGF (R & D Systems). After expansion for
four days, bFGF was removed to induce differentiation to neuronal
phenotypes. In some cases, 500 ng/mL Shh-N (R & D Systems) and
100 ng/mL FGF-8 (R & D Systems) was added during NP (neuronal
precursor) expansion stage and 200 mM ascorbic acid (Sigma) was
added during ND (neuronal differentiation) stage for further induction
of DA phenotype (Lee et al., 2000). Cells were eventually ®xed
15 days after starting neuronal differentiation.
Plasmid construction
To generate the pEF/Nurr1/IRES/hrGFP plasmid, mouse Nurr1
cDNA was PCR-ampli®ed and inserted into the Sal I and BstE II
sites of the pEF/IRES/hrGFP vector (Chung et al., 2002). The
insertion of Nurr1 cDNA into the vector was con®rmed by restriction
digestion and sequence analysis. The Nurr1 construct was further
con®rmed by a transient cotransfection assay, where it activated a
reporter construct containing Nurr1-binding sites (Murphy et al.,
1996) (data not shown). A DNA cassette containing the neomycin
resistant gene (EC-Neo, Stratagene, La Jolla, CA) was inserted into
both pEF/IRES/hrGFP and pEF/Nurr1/IRES/hrGFP using cre recom-
binase according to the manufacturer's instruction. Each construct
with the neomycin resistant cassette was con®rmed by restriction
digestion and then used for stable transfection of ES cells.
Stable transfection and isolation of Nurr1-expressing ES cell
lines
D3 cells were transfected with either pEF/IRES/hrGFP or pEF/Nurr1/
IRES/hrGFP using the lipofectamine plus reagent (Life
Technologies). Stably transfected cells were selected in ES medium
containing 500 mg/mL Neomycin (G418 Sulphate, Clontech, Palo
Alto, CA). Neomycin-resistant clones were isolated from individual
colonies, expanded, and total RNAs were prepared from each clone
using TriReagent (Sigma). After DNaseI treatment (DNA-free,
Ambion, Austin, TX), expression of hrGFP or Nurr1 was tested by
RT-PCR using the rTth RT-PCR kit (Applied Biosystems, Foster
City, CA) according to the manufacturer's instruction. The primer
sets used for Nurr1 were Nurr517 (5¢-AGTACCTTTATGGAC-
AACTACAGCA-3¢) and Nurr816R (5¢-CGTAGTGGCCACGTAGT-
TCTGGT-3¢). For hrGFP, hrGFP-5 (5¢-CAGATCCGCGTGACCAA-
GGGCGCC-3¢) and hrGFP-3 (5¢-AGGCCGCCGTCCTCGTAG-
CGCAGG-3¢). The cDNA quality was measured with the exon 3
speci®c actin primers (5¢-GGTGATGACCTGGCCGTCAGGCA-
GCTCGTA-3¢) and (5¢-AACCCCAAGGCCAACCGCGAGAAG-
ATGACC-3¢).
Immunocytochemistry
For immuno¯uorescence staining, cells were ®xed in 4% formalde-
hyde (Electron Microscopy Sciences, Ft. Washington, PA) for
30 min, rinsed with PBS and then incubated with blocking buffer
(PBS, 10% normal donkey serum; NDS) for 10 min. Cells were then
incubated overnight at 4 °C with primary antibodies diluted in PBS
containing 2% NDS. The following primary antibodies were used:
mouse TuJ1 (Covance, Richmond, CA; 1 : 500), rabbit antib-tubulin
(Covance; 1: 2000), sheep anti-TH (Pel-Freez, Rogers, Arkansas;
1 : 200), rabbit anti-TH (Pel-Freez; 1 : 200), mouse anti-TH
(Chemicon, Temecula, CA; 1 : 200), rabbit antiserotonin; 5HT
(DiaSorin, Stillwater, MN; 1 : 2500), sheep antiaromatic L-amino
acid decarboxylase; AADC (Chemicon; 1 : 200), rat antidopamine
transporter; DAT (Chemicon; 1 : 2000), goat anticalretinin (Swant,
Bellinzona, Switzerland; 1 : 1000), rabbit anticholine acetyltransfer-
ase; ChAT (Chemicon; 1 : 500), rabbit antigamma aminobutyric
acid; GABA (Sigma; 1 : 1000), rabbit antiglutamate; Glu (Sigma;
1 : 200), rabbit antiglial ®brillary acidic protein; GFAP (DAKO,
Denmark; 1 : 500), mouse antigalactocerebrosidase C; GalC
(Chemicon; 1 : 500). After additional rinsing in PBS, the coverslips
were incubated in ¯uorescent-labelled secondary antibodies (Cy2-,
Rhodamine Red-X-, or Cy5-labelled donkey IgG; Jackson
Immunoresearch Laboratory) in PBS with 2% NDS for 30 min at
room temperature. After rinsing for 3 3 10 min in PBS, sections
were mounted onto slides in Gel/Mount (Biùmeda Corp., Foster City,
CA). Coverslips were examined using a Leica TCS/NT confocal
microscope equipped with krypton, krypton/argon and helium lasers.
Cell counting and statistical analysis
Cell density of DA neurons was determined by counting the numbers
of TH+ cells and the numbers of b-tubulin+ cells per ®eld at 63 3
magni®cation using a Zeiss Axioplan I ¯uorescent microscope.
Counting was performed on blind coded samples (cultures grown on
the coverslips) by two independent investigators per sample. Ten
visual ®elds were randomly selected and counted for each sample,
and cell densities were calculated by dividing the numbers of TH+
cells by that of b-tubulin+ cells. Numbers presented in ®gures
represent the average percentage and standard error of mean (SEM)
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of TH+ cells over b-tubulin+ cells from ®ve samples per ES cell
clone.
For statistical analysis, we used Statview software and performed
analysis of variance (ANOVA) with an alpha level of 0.01 to determine
possible statistical differences between group means. When signi®-
cant differences were found, posthoc analysis was performed using
Fisher's PLSD (a = 0.05)
RNA preparation and semiquantitative RT-PCR
Total RNA from plated cells at different stages in the differentiation
protocol was prepared using the TriReagent (Sigma) followed by
treatment with DNase I (Ambion). For RT-PCR analysis, 5 mg RNA
was transcribed into cDNA with the SuperScriptTM. Preampli®cation
Kit (Life Technologies) and oligo (dT) primers. The cDNA was then
analysed in a PCR assay using the following primers.
TH: 5¢-TCCTGCACTCCCTGTCAGAG-3¢,
5¢-CCAAGAGCAGCCCATCAAAGG-3¢, 423 bp;
AADC: 5¢-CCTACTGGCTGCTCGGACTAA-3¢,
5¢-GCGTACCAGGGACTCAAACTC-3¢, 715 bp;
DAT: 5¢-CAGAGAGGTGGAGCTCATC-3¢,
5¢-GGCAGATCTTCCAGACACC-3¢, 328 bp;
Ptx3: 5¢- CTCTCTGAAGAAGAAGCAGCG-3¢,
5¢-CCGAGGGCACCATGGAGGCAGC-3¢, 491 bp;
AHD2: 5¢-CTGCAAGTGAGGAGGTCATC-3¢,
5¢-CTGCTGGCTTGACAACCAC-3¢, 458 bp;
Calbindin: 5¢-GCAGTCATCTCTGATCACAGC-3¢,
5¢-GAGGTCTGTGTACTCTGCTAG-3¢, 428 bp;
DBH: 5¢-CTGGACAGGCATAAATGGCAG-3¢,
5¢-GTCTTGCTGGGAATCCAGATG-3¢, 449 bp;
GluT: 5¢-AAAGTTCAGAGCCTCACCAAG-3¢,
5¢-GATCAAATCCAGGAAGGCATC-3¢, 429 bp.
PCR reactions were carried out with 1 3 IN Reaction Buffer
(Epicentre Technologies, Madison, WI), 1.4 nM of each primer, and
2.5 units of Taq I DNA polymerase (Promega, Madison, WI).
Samples were ampli®ed in an Eppendorf Thermocycler (Brinkmann
Instruments, Westbury, NY) under the following conditions:
denaturing step at 95 °C, 40 s; annealing step at 60 °C, 30 s;
ampli®cation step at 72 °C, 1 min for 20±25 cycles and a ®nal
ampli®cation step at 72 °C, 10 min. For the semiquantitative PCR,
cDNA templates were normalized by amplifying actin-speci®c
transcripts and levels of gene transcription were detected by adjusting
PCR cycling and primer design in such a way that each primer set
ampli®ed its corresponding gene product at its detection threshold to
avoid saturation effects.
Analysis of catecholamines
Differentiated ES cells in 6 well plates were treated with 200 mL N3
medium supplemented with 50 mM KCl and 0.1 mM Pargyline and
the media were collected after 30 min and concentrated solutions of
perchloric acid (PCA) were added for a ®nal concentration of 0.1 M
PCA/0.1 mM EDTA. For measurement of catecholamine cell con-
tents, cells were harvested in 0.1 M PCA/0.1 mM EDTA. These
deproteinated samples were centrifuged and the supernatants were
kept at ±80 °C until further analysis. Samples were further puri®ed by
using a nylon ®lter 0.22 mm (Osmonics Inc.) then analysed for their
catecholamine content by reverse-phase HPLC using a Velosep RP-
18 column (100 3 3.2 mm, Brownlee Laboratories) and an ESA
Coulochem II electrochemical detector equipped with a 5014
analytical cell as described previously (Wachtel et al., 1997). The
mobile phase was composed of a 0.1 M sodium phosphate buffer
(pH 2.65), 0.1 mM EDTA, 0.4 mM sodium octyl sulphate, and 9%
(v/v) methanol. The ¯ow rate of the mobile phase through the system
was 0.8 mL/min. The potential of the guard cell was set at 330 mV.
The potential of the ®rst electrode in the analytical cell was set at
0 mV, the second at 310 mV. L-DOPA, dopamine, dihydroxyphenyl
acetic acid (DOPAC) and homovanillic acid (HVA) were identi®ed
by retention time and quanti®ed based on peak height using an
EZChrom Chromatography Data System. The limit of detection for
all compounds was < 1 pg.
DA content of each sample was normalized with the amount of
total cellular proteins. For protein measurement, after harvesting cells
in 0.1 M PCA/0.1 mM EDTA, precipitates were resuspended in
10 mM potassium phosphate buffer with 0.2% triton-X, pH 7 and
sonicated. The protein content was measured by Bradford method
(Bio-Rad Assay, Bio-Rad Laboratories, Hercules, CA) (Bradford,
1976).
Results
Exogenous expression of Nurr1 increases the differentiation of
ES cells to TH+ neurons
Using the expression vector pIRES/hrGFP (Stratagene), it has been
previously shown that transgene expression in ES cells is most
ef®cient when linked to the cellular elongation factor-1a (EF)
promoter (Chung et al., 2002). The expression vector pEF/Nurr1/
IRES/hrGFP was thus constructed to generate Nurr1-overexpressing
D3 ES cell lines. From 18 G418-resistant clones, six were found to
express Nurr1 (Fig. 1) and two (D3-N2 and D3-N5) were selected for
the in vitro differentiation experiments. After expansion of these
clones, hrGFP expression was no longer detected either by ¯uores-
cent microscopy or RT-PCR, in spite of continuous Nurr1 expression
(see below), possibly due to genetic instability of the IRES element.
In addition, D3 cells were also transfected with the empty vector
pEF/IRES/hrGFP as a control. Out of eight G418-resistant clones,
FIG. 1. Isolation of ES cell clones that express Nurr1. D3 ES cells were
transfected with either the Nurr1-expressing vector pEF/Nurr1/IRES/hrGFP
or with empty vector pEF/IRES/hrGFP as a negative control, followed by
selection of neomycin-resistant clones and screening for either Nurr1
(N1±N6, upper panel) or hrGFP expression (empty vector-transfected
clones, E1±E5, lower panel) by RT-PCR (shown are representative
samples). *The clones that were selected for further analysis.
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four clones expressed hrGFP (Fig. 1) and clone D3-E5 was selected
as a control for the experiments presented in this report.
To address whether exogenous Nurr1 expression may directly
in¯uence in vitro differentiation of D3 ES cells to the DA phenotype,
induction of the TH protein, the ®rst and rate-limiting step of DA
synthesis, was analysed using a modi®cation of a previously reported
differentiation protocol (Lee et al., 2000). Brie¯y, cells were ®rst
grown to form embryoid bodies (EB), followed by selection and
expansion of Nestin+ neural precursors, and differentiation into neural
subtypes (see Materials and Methods). Both of the Nurr1-expressing
clones, D3-N2 and D3-N5 showed signi®cantly increased proportions
of TH+ neurons as compared to parental D3 and control D3-E5 cells
(Fig. 2a±f).
In both naõÈve and Nurr1-overexpressing D3 cells, many TH+
neurons were present in clusters, with more TH+ clusters apparent in
the latter cell population. Thus, to ensure a more quantitative
analysis, a cell counting method was designed using a grid of 10
random ®elds, which was applied to ®ve coverslips per analysis for
appropriate statistical sampling (see Materials and methods for
details). All samples were blind-coded and two independent
investigators counted the same sample to ensure an unbiased
analysis. This counting method revealed the presence of
3.6 6 1.3% and 4.2 6 1.4% TH+/b-tubulin+ neurons for naõÈve D3
and the control D3-E5 cell line, respectively, and 14.4 6 2.0% and
18.0 6 2.6% for the two Nurr1-transgenic ES cell clones (the
average percentage 6 SEM; Fig. 2g), thus demonstrating that
exogenous expression of Nurr1 in ES cells leads to a 4±5-fold
increase in TH+ cell differentiation under these experimental
conditions. As TH+ cells were counted after 15 days of neuronal
differentiation (ND), it was next investigated whether TH is induced
FIG. 2. Exogenous expression of Nurr1 in ES cells increases the number of
TH+ neurons after in vitro differentiation. (a±f). Detection of b-tubulin
(rabbit antib-tubulin and Cy2-antirabbit IgG, green) and TH (sheep anti-TH
and Rhodamine Red-X-antisheep IgG, red) in in vitro differentiated D3 and
D3-N5 cells by immunocytochemistry. Shown are representative ®elds using
confocal microscopy at a 403 magni®cation. Scale bar, 25 mm. (g)
Quanti®cation of TH+ neurons. b-tubulin+ and TH+ cells from in vitro
differentiated D3, D3-E5, D3-N2 and D3-N5 ES cells were counted on
10 random ®elds per each sample, and cell densities of TH+ neurons were
calculated by dividing the numbers of TH+ cells by that of b-tubulin+ cells.
Each group represents an average of 5 samples from 2 to 3 independent
experiments. ANOVA revealed F = 8.95, P < 0.01. Fisher's PLSD posthoc
analysis was performed with a signi®cance level of 0.05. *P < 0.05
compared with D3 and D3-E5 cells.
FIG. 3. Exogenous expression of Nurr1 correlates with expression of other
markers speci®c for midbrain DA neurons. Detection of TH and AADC
(a±f), DAT (g±i), calretinin (j±l), GABA (m±o) and 5HT (p±r) on D3-N5
ES cells after in vitro differentiation. Sheep anti-TH was used for all
staining except the double staining with AADC, where rabbit anti-TH was
used. All other primary antibodies are as described in materials and
methods. Cy2-labelling of secondary antibodies was shown as green,
Rhodamine Red-X as red, and Cy5 as blue. Samples were analysed with
either 40 3 or 80 3 magni®cation. Scale bar, 25 mm.
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at an earlier period in the Nurr1-expressing clones. Whereas very
limited numbers of TH+ neurons were detected at day 6 of ND, it was
observed that there was a marked increase of TH+ neurons in D3-N5
cells at day 10, and the same high levels of TH+ neurons were
maintained until day 15 (data not shown). This was also con®rmed by
reverse phase high performance liquid chromatography (HPLC)
analysis of DA production (see below). These results indicate that the
DA phenotype was induced by Nurr1 expression in a stage-speci®c
manner in this ES cell system.
Exogenous expression of Nurr1 directs the ES cells to
express other midbrain DA markers
It was next determined whether these TH+ neurons expressed other
midbrain DA markers. To this end, the in vitro differentiated D3 or
D3-N5 cells were double-stained using antibodies against TH and
AADC. AADC is involved in the last step of DA biosynthesis. As
shown in Fig. 3a±f, all of the TH+ neurons were also AADC+,
however, some of the cells had an AADC+/TH± phenotype (Fig. 3d±
f), suggesting the presence of serotonergic neurons (see below). It
was also examined whether the TH+ neurons coexpressed DAT. As
shown in Fig. 3g±i, some of the TH+ cells were also DAT+, indicating
that these cells have acquired a mature DA phenotype. In addition,
most of the TH+ cells were also positive for calretinin (Fig. 3j±l),
which is expressed in many midbrain and olfactory DA neurons
(Nemoto et al., 1999). Most of TH+ cells did not express gamma
aminobutyric acid (GABA, Fig. 3m±o), suggesting that these TH+/
GABA± neurons have the midbrain, but not olfactory, DA phenotype.
Furthermore, double-immunocytochemistry showed that these TH+
cells did not coexpress 5HT (Fig. 3p±r) or dopamine b-hydroxylase
(DBH; data not shown).
FIG. 4. Semi-quantitative RT-PCR analysis of midbrain DA markers during
in vitro differentiation of D3 vs. D3-N5 cells. Samples from undifferentiated
ES cell stage (ES) in the presence of LIF, nestin+ neuronal precursors (NP)
and fully differentiated neurons after 15 days of neuronal differentiation
(ND) were analysed for speci®c marker gene expression. To avoid
saturation effect, the numbers of PCR cycles were experimentally
determined for each cDNA, such that ampli®cation of speci®c transcript is
in a linear range. RT-PCR analyses were repeated twice using RNA
samples prepared from two independent in vitro differentiation experiments,
resulting in similar results. In addition, a same pattern was obtained when
D3-E5 and D3-N2 substituted for D3 and D3-N5, respectively.
FIG. 5. Nurr1 overexpression in ES cells does not in¯uence the
differentiation into neural phenotypes other than DA and serotonergic
neurons. Detection of GABA (a and b), choline acetyltransferase ChAT; (c
and d) and glutamate Glu; (e and f) positive neurons as well as b-tubulin
and glial ®brillary acidic protein GFAP (g and h) or galactocerebrosidase C
GalC (i and j) on in vitro differentiated D3 and D3-N5 cells. For double
labelling with GFAP, mouse Tuj1 was used and for double labelling with
GalC, rabbit antib-tubulin was used. All other primary antibodies are as
described in materials and methods. For a-f, Rhodamine Red-X-labelled
secondary antibodies are used, and for g-j, Cy2-labelling of secondary
antibodies was shown as green, Rhodamine Red-X as red, and Cy5 as blue.
Confocal microscopy at 40 3 magni®cation. Scale bar, 25 mm.
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Semiquantitative RT-PCR analysis was then done in order to
determine the expression of midbrain DA neuron-speci®c molecules
at the different stages of in vitro differentiation of D3, D3-E5, D3-N2
and D3-N5 (Fig. 4 and data not shown). It is worth noting that Nurr1
expression was persistently maintained and up-regulated in Nurr1-
transduced clones during all three stages of in vitro differentiation, as
compared to D3 or D3-E5 (Fig. 4 and data not shown). This contrasts
with other studies in which Nurr1 expression was later shut down
after the initial screening of Nurr1-expressing clones (Wagner et al.,
1999). These dissimilar patterns may be due to the different
promoters used in each study to drive Nurr1 expression. The EF-1a
promoter used in this study was shown to have active promoter
activity during different stages of in vitro ES cell differentiation
(Chung et al., 2002). Consistent with the immunocytochemistry data,
mRNA expression from the TH, AADC and DAT genes were up-
regulated in both D3-N2 and D3-N5 cells after in vitro neuronal
differentiation (ND). Interestingly, it was not possible to detect clear
induction of TH and DAT gene expression at the initial (ES) or
neuronal precursor (NP) stages of differentiation (Fig. 4). In contrast,
there was an increase in AADC transcription detected in undiffer-
entiated Nurr1-expressing clones. In addition, the altered expression
of other midbrain DA markers was examined including aldehyde
dehydrogenase 2 (AHD2), Ptx3 and calbindin. Compared to the
parental D3 cells, expression of all three genes was markedly up-
regulated in both D3-N2 and D3-N5 clones (Fig. 4 and data not
shown). In contrast to these midbrain DA markers, there was no DBH
mRNA expression in any of the D3, D3-E5, D3-N2 or D3-N5 cells
and no difference in the expression levels of the neuron-speci®c
glutamate transporter mRNA (Tanaka, 1993). Given that these are
markers for noradrenergic and glutamatergic neurons, respectively,
this data indicates a speci®c effect of Nurr1 on the expression of
midbrain DA neuronal markers (see below).
Effect of exogenous Nurr1 expression on the differentiation of
neural phenotypes other than DA neurons
The effect of Nurr1 on the differentiation of ES cells into other neural
phenotypes was next investigated, using various neuronal and non-
neuronal molecules. Both D3 and D3-N5 cells generated GABA
(Fig. 5a and b), choline acetyltransferase (ChAT, Fig. 5c and d), and
glutamate (Glu, Fig. 5e and f) positive neurons in similar amounts,
indicating that Nurr1 does not affect the differentiation into these
FIG. 6. (a) Induction of TH+ neurons by Nurr1 in the presence of signalling
molecules. D3 or D3-N2 cells were differentiated in vitro with or without
signalling molecules (Shh, FGF8, and AA). TH+ neurons were quanti®ed as
described in Materials and methods and in Fig. 2g. Each group represents
an average of 3±5 samples from 2 to 3 independent experiments. ANOVA
revealed F = 68.5, P < 0.0001. Fisher's PLSD posthoc analysis was
performed with a signi®cance level of 0.05. #P < 0.05 compared with D3
cells. *P < 0.05 compared with all other groups. b. Quanti®cation of b-
tubulin+ cells. Shown are the numbers of total b-tubulin+ cells from 10
random ®elds per each sample (n = 4±5). ANOVA revealed F = 0.296,
P = 0.909, showing that there is no signi®cant difference among group
means.
FIG. 7. Analysis of dopamine release. In vitro differentiated ES cell clones
were challenged with 50 mM KCl, and the media assayed for DA levels by
reverse phase HPLC. DA release from ES cell clone-derived DA neurons
was measured at day 5 and day 11 of ND stage. Each group represents an
average of 3±4 samples from independent experiments. ANOVA revealed
F = 14.19, P < 0.0001. Fisher's PLSD posthoc analysis was performed with
a signi®cance level of 0.05. *P < 0.05 compared with all other samples.
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neuronal subtypes. In case of the glutamatergic neuronal phenotype,
the immunohistochemical results were con®rmed by RT-PCR
showing that the neuronal glutamate transporter gene was equally
expressed in D3 and D3-N5 clones (Fig. 4). Based on previous
studies showing that ES cells can differentiate to a serotonergic
phenotype in vivo (Deacon et al., 1998; BjoÈrklund et al., 2002) or
in vitro (Lee et al., 2000), ES cells were also examined using
antibodies against 5HT following in vitro differentiation. The
numbers of 5HT+ neurons in the D3-N2 and D3-N5 clones were
1.8- and 3.4-fold that seen in the D3-E5 clone, respectively (data not
shown), suggesting the possibility that exogenous expression of
Nurr1 may modestly increase the proportion of serotonergic neurons.
One possible explanation for this observation is that increased
expression of AADC may contribute to the higher level of
serotonergic neurons as well as DA neurons. Finally, the glial cell
population was analysed using speci®c antibodies for astrocytes
(GFAP) and oligodendrocytes (GalC). Both glial cell populations
could be detected in similar amounts in D3 and D3-N5 clones
(Fig. 5g±j; other data not shown). Taken together, these data suggest
that Nurr1 may have a relatively speci®c effect on ES cell
differentiation into DA neurons.
Signalling molecules synergistically increase the differentiation
of Nurr1-expressing ES cells to DA neurons
Several signalling molecules such as Sonic hedgehog (Shh) and FGF8
have been well characterized to facilitate DA differentiation (Ye et al.,
1998; Lee et al., 2000). One interesting possibility is that Nurr1 acts
downstream of one or more of these signalling pathways.
Alternatively, Nurr1 may act independently of these pathways and,
if so, may co-operatively facilitate induction of DA phenotypes. To
address these possibilities, we sought to apply the recently optimized
treatment of Shh, FGF8, and ascorbic acid (AA) (Lee et al., 2000) to
our Nurr1-expressing clone. When these molecules were added to the
wild type D3 cells, formation of TH+ neurons increased from
3.6 6 1.3% to 11.1 6 1.6% of the b-tubulin+ neurons (Fig. 6a).
Therefore, while the proportion of TH+ neurons was lower than that
reported by Lee et al., (2000), the amount of increase was similar
(approximately 3-fold). The same treatment was next applied to the
D3-N2 clone during in vitro differentiation. In this case, almost all
cell clusters contained large numbers of TH+ neurons and the
counting analysis showed that approximately 61.9 6 3.9% of all
b-tubulin+ neurons were TH+ (Fig. 6a). Thus, combined treatment of
Shh, FGF8, and AA increased the proportion of D3-N2-derived TH+
neurons 4- to 5-fold, indicating that Nurr1 may facilitate DA neuron
differentiation independently of these signal molecules.
To address whether Nurr1 and/or these signalling molecules may
increase the proportion of TH+ neurons by facilitating neurogenesis,
the numbers of b-tubulin+ neurons for 10 ®elds of each sample
(n = 4±5) of different ES cell clones were counted, with or without
the addition of signalling molecules. As shown in Fig. 6b, Nurr1
overexpression, signalling molecules, or their combination did not
obviously increase the formation of b-tubulin+ neurons.
Nurr1-expressing ES cell-derived neurons ef®ciently produce
and release DA in response to membrane depolarization
An important physiological aspect of authentic DA neuron pheno-
types is the ability to synthesize DA and release it in response to
membrane depolarization. When ES cells were harvested at time
points earlier than the ND stage (day 5) and assayed by HPLC, DA
was not detectable in the cell pellets (data not shown) or in the media
after KCl depolarization (Fig. 7), 0.00 6 0.00, 0.00 6 0.00,
0.01 6 0.01 pg/mg cellular proteins, for D3, D3-E5, and D3-N2,
respectively. In contrast, when fully in vitro differentiated ES cell
clones (day 11 of the ND stage) were assayed, total DA contents
within the cells were 0.54 6 0.24, 0.37 6 0.15, and 1.11 6 0.15
pg/mg cellular proteins, for D3, D3-E5, and D3-N2, respectively
(n = 3, P < 0.001). Following these results it was tested whether DA
can be released following membrane depolarisation, after treatment
of fully differentiated ES cell clones (day 11 of ND stage) with
50 mM KCl, the released DA in the media was 0.31 6 0.09,
0.21 6 0.11, and 0.68 6 0.10 pg/mg cellular proteins for D3, D3-
E5, and D3-N2, respectively (Fig. 7). These data demonstrate that
neurons derived from Nurr1-overexpressing ES clones have the
enhanced ability to produce and release DA as compared to naõÈve ES
cells. Taken together, one may conclude that exogenous Nurr1
expression in ES cells increases the ef®ciency of generating
phenotypically and functionally mature midbrain DA neurons in vitro.
Discussion
The current study analysed the effect of Nurr1 on uncommitted
pluripotent mouse ES cells and showed that overexpression of this
transcription factor enhances the development of these cells into
midbrain DA neurons. The effect of Nurr1 expression in ES cells on
differential gene expression during cell development was also
examined. It was found that there was selective up-regulation of
the midbrain DA-speci®c markers TH, AADC, DAT, Ptx3, calbindin,
and AHD2 in Nurr1-expressing ES cell clones (Figs 3 and 4). While
TH and AADC mediate the ®rst and last step of DA biosynthesis,
respectively, DAT is responsible for DA reuptake into the presynaptic
terminal. AADC is also expressed in serotonergic neurons, mediating
the last step of serotonin biosynthesis. Ptx3 is one of the most
selective midbrain DA markers (Smidt et al., 1997) and is a putative
transcription factor whose function is unknown. AHD2 has been
de®ned as the earliest marker identi®able in developing DA cells
(Wallen et al., 1999). Some of these markers were either absent or
signi®cantly down-regulated in midbrain DA neurons of Nurr1-null
mice (Zetterstrom et al., 1997; Castillo et al., 1998; Saucedo-
Cardenas et al., 1998; Wallen et al., 1999; Witta et al., 2000).
However, it was not clear whether this reduction was due to the direct
action of Nurr1 or defective neurogenesis. The gene expression
analysis, using a gain of function approach, demonstrated the
importance of Nurr1 for the expression of these genes in developing
ES cells. A clear up-regulation of AADC, Ptx3 and AHD2 gene
expression was observed in the Nurr1-transgenic ES clones, com-
pared to the D3 or D3-E5 clones during in vitro differentiation (Fig. 4
and other data not shown). Interestingly, the markers for the mature
DA phenotype such as TH and DAT were expressed only at the fully
differentiated stage. Collectively, this data suggests that Nurr1 is
involved in the induction and/or maintenance of expression of various
midbrain DA neuronal markers.
The observation that TH gene induction occurs after attainment of
a mature neuronal phenotype indicates that Nurr1 alone is not
suf®cient for activating TH gene expression, but rather requires
speci®c cellular (or neuronal) environments or cofactors. Such
cofactors or conditions may be present in Nurr1-overexpressing
adult hippocampal precursors (Sakurada et al., 1999), or provided by
mesencephalic astrocytes to allow TH induction in C17.2 neuronal
precursors (Wagner et al., 1999). In addition, we and others have
recently demonstrated that Nurr1 can directly activate the TH
promoter in a cell line-speci®c manner (Sakurada et al., 1999; Chung
et al., 2000; Iwawaki et al., 2000; Jensen & O'Malley, 2001),
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supporting the view that certain transcriptional conditions are
required for TH gene induction by Nurr1.
Up-regulation of DAT gene expression was observed in the fully
differentiated Nurr1-transgenic cells. Whereas few DAT+ cells could
be detected after neuronal differentiation of naõÈve D3 cells (data not
shown), many DAT+ neurons were detected among the TH+ cell
population of differentiated D3-Nurr1 cells (Fig. 3). This was
consistent with the RT-PCR analysis demonstrating that expression
of DAT mRNA was signi®cantly up-regulated in D3-Nurr1 cells after
differentiation. Nurr1 has been shown to enhance the transcriptional
activity of the human DAT gene (Sacchetti et al., 1999), and in
addition, DAT up-regulation in vivo depends on interaction between
presynaptic DA ®bres and target striatal neurons (Perrone-Capano
et al., 1994; Perrone-Capano et al., 1996). While only some of the
TH+ cells expressed DAT in these experiments, it might be possible
to increase the proportion of DAT expressing cells by providing
target cells. In support of this, it has previously been shown that even
in naive D3 cells, there is abundant DAT expression after in vivo
transplantation into striatum of rodent PD model animals (BjoÈrklund
et al., 2002).
Various signalling molecules have been extensively tested for their
potential to facilitate DA lineage differentiation using ES and
progenitor cells (Ye et al., 1998; Kawasaki et al., 2000; Lee et al.,
2000; Rolletschek et al., 2001). Among these factors, we tested if the
combined treatment of Shh, FGF8, and AA (Lee et al., 2000) can
increase formation of TH+ neurons in the Nurr1-transduced ES cell
clone. This treatment increased formation of TH+ neurons in D3 ES
cells approximately 3-fold (from 3.6 6 1.3% to 11.1 6 1.6%;
Fig. 6a). When the same treatment was applied to the D3-N2 clone
during in vitro differentiation, formation of TH+ neurons was robustly
increased. In this condition, most of neuronal clusters contained large
numbers of TH+ neurons and our counting analysis showed that
approximately 61.9 6 3.9% of all b-tubulin+ neurons were TH+
(Fig. 6a). This observation therefore does not support the idea that
Nurr1 may act downstream of one of these signalling molecules, but
rather, suggests that Nurr1 and these molecules may act independ-
ently or synergistically to induce the DA lineage differentiation.
Different mechanisms may underlie the increase of TH+ neurons
by Nurr1 overexpression and/or signalling molecules. First, they may
facilitate neurogenesis at the level of formation of neuroprogenitor
cells or neurons, the results described here show that the numbers of
b-tubulin+ neurons were not changed in any of ES cells and therefore
do not support this possibility (Fig. 6b). Consistent with this, analyses
of Nurr1-de®cient mice also indicated that Nurr1 acts at the later
stage of DA differentiation (Zetterstrom et al., 1997; Castillo et al.,
1998; Saucedo-Cardenas et al., 1998; Wallen et al., 1999; Witta et al.,
2000). Another possible mechanism by which Nurr1 can increase DA
differentiation is by in¯uencing DA cell populations at the cell
survival and/or death level. In Nurr1-null mice, Saucedo-Cardenas
et al., (1998) observed increased apoptosis and decreased cell
numbers in the midbrain of Nurr1-null neonates, indicating that Nurr1
is important in the survival of midbrain DA neurons. This possibility
is consistent with the observation that Nurr1 critically regulates
expression of Ret, an important receptor for glial cell line-derived and
related neurotrophic factors (Wallen et al., 2001). On the other hand,
Witta et al., (2000) did not observe such an effect in their Nurr1-null
mice. Thus, at this point in time, the effect of Nurr1 on DA cell
survival is not clear. The data reported here does not address these
possibilities, as cell survival or death was not measured directly in
this culture system. It is thus an open possibility that Nurr1 may have
pleiotropic effects on DA gene induction and cell survival, thereby
enhancing the fraction of DA neurons in our in vitro system.
It appears that exogenous expression of Nurr1 has a relatively
speci®c effect on DA lineage differentiation. When other neuro-
transmitter subtypes such as GABA, cholinergic, noradrenergic, and
glutamatergic marker proteins were analysed, formation of these
neuronal subtypes was apparently unaltered in Nurr1-transduced ES
cells. In support of this, semiquantitative RT-PCR analysis con®rmed
that expression of the neuronal glutamate transporter and DBH genes,
markers of glutamatergic and noradrenergic neurons, respectively,
was not changed in the D3 and D3-N5 clones (Fig. 4). In addition,
Nurr1 had no detectable effect on the formation of glial cell
populations such as astrocytes and oligodendrocytes, suggesting that
Nurr1 may speci®cally in¯uence the DA neuron lineage. One
possible exception may be the number of serotonergic neurons,
which seem to have been modestly increased by Nurr1 over-
expression. A possible explanation for this observation is that AADC,
the ®nal step for both DA and serotonin synthesis, was up-regulated
in Nurr1-overexpressing clones in our study (Fig. 4), possibly
contributing to the appearance of 5HT+ neurons. However, as only
one Nurr1-expressing clone (out of two) signi®cantly elevated 5HT+
neuronal numbers, this observation should be considered preliminary
and awaits further investigation.
Several lines of evidence suggest that the TH+ neurons observed in
this study have the midbrain DA neuronal phenotype. First, double-
immunostaining analysis showed that most of TH+ neurons coexpress
other midbrain DA neuron markers such as AADC and calretinin.
Additionally, some of these cells also coexpressed DAT, another
essential marker protein of mature DA neurons, and none of them
expressed DBH, a noradrenergic marker. Notably, most of these
TH+/calretinin+ cells did not express GABA (Fig. 3m±o), suggesting
that these neurons have the midbrain, but not olfactory, DA
phenotype. Furthermore, these TH+ cells did not coexpress other
neurotransmitters such as 5HT (Fig. 3p±r). Finally, a critical criterion
of authentic DA neuron phenotypes is the ability to synthesize DA
and release it in response to membrane depolarization. The HPLC
analysis of in vitro differentiated ES cells showed that signi®cant
amounts of DA were produced and, then, released in response to
membrane depolarization by 50 mM KCl (Fig. 7), strongly suggesting
that Nurr1 overexpression facilitates the differentiation of ES cells to
the authentic midbrain DA neuron lineage.
In vitro differentiation of the genetically modi®ed ES cells to the
DA lineage can be further increased, when combined with the
induction procedure using several signalling molecules (Ye et al.,
1998; Hynes & Rosenthal, 1999, 2000; Kawasaki et al., 2000; Lee
et al., 2000; Caldwell et al., 2001; Rolletschek et al., 2001). Two
groups have recently shown that human ES cells can differentiate into
neuronal cell types in vitro (Reubinoff et al., 2001; Studer, 2001;
Zhang et al., 2001). However, generation of DA neurons was very
limited in both studies. Therefore, it is of great interest to determine
whether the genetic and inductive manipulations described here could
be applied to improve the generation of DA neurons in human ES
cells. Previous work has also demonstrated that transplantation of
naõÈve ES cells in a rat model of PD resulted in spontaneous
differentiation into functional DA neurons partially restoring
behavioural de®cits (Deacon et al., 1998; BjoÈrklund et al., 2002).
Given the increased yield of DA neurons in Nurr1-transgenic ES
cells, it may be to evaluate the function of these genetically modi®ed
cells in rodent and primate models of PD. In parallel with the above
®ndings, McKay and colleagues similarly report that DA neurons can
be ef®ciently generated from Nurr1-overexpressing embryonic stem
cells and showed that grafting of these in vitro differentiated DA
neurons resulted in functional recovery in a rodent model of PD (Kim
et al., 2002).
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Taken together, these results demonstrate that ES cells can be
genetically manipulated by key cell fate-determining transcription
factor(s) to facilitate their differentiation into speci®c cell lineages.
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